Renaissance Technologies - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 77 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2021$76,000
-74.8%
19,461
-68.9%
0.00%
Q3 2021$302,000
-53.7%
62,520
-38.7%
0.00%
-100.0%
Q2 2021$652,000
-44.8%
101,970
-45.8%
0.00%0.0%
Q1 2021$1,182,000
-3.0%
188,161
+6.4%
0.00%0.0%
Q4 2020$1,219,000
+1039.3%
176,861
+420.8%
0.00%
Q4 2019$107,000
-94.3%
33,961
-85.4%
0.00%
-100.0%
Q2 2018$1,868,0000.0%232,0980.0%0.00%
-50.0%
Q1 2018$1,868,000232,0980.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q2 2018
NameSharesValueWeighting ↓
Western Standard LLC 869,354$2,895,0003.47%
22NW, LP 1,241,896$4,136,0002.24%
Newtyn Management, LLC 1,199,606$3,995,0001.46%
WITTENBERG INVESTMENT MANAGEMENT, INC. 186,198$620,0000.35%
Yakira Capital Management, Inc. 66,934$223,0000.10%
Sepio Capital, LP 210,534$701,0000.08%
Nantahala Capital Management 747,635$2,490,0000.08%
Watson Rebecca 3,068$10,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 61,700$205,0000.00%
WEBSTER BANK, N. A. 3,055$10,0000.00%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders